| Kristy Marie Lantz, | |
|
4040 Tamarack Dr, Parma, OH 44134-6266 | |
| (440) 572-1337 | |
| Not Available |
| Full Name | Kristy Marie Lantz |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4040 Tamarack Dr, Parma, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033623624 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP12779 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kristy Marie Lantz, 4040 Tamarack Dr, Parma, OH 44134-6266 Ph: (440) 572-1337 | Kristy Marie Lantz, 4040 Tamarack Dr, Parma, OH 44134-6266 Ph: (440) 572-1337 |
News Archive
Scientists at the Buck Institute for Age Research have discovered that a particular family of enzymes are involved in the breakdown of proteins that modify the production of toxic fragments that lead to the pathology of Huntington's disease. These enzymes, matrix metalloproteinases, provide new targets for drug therapies for the disease - targets that have already been shown to respond to cancer drugs currently in clinical development.
Elsevier, a world-leading publisher of scientific, technical and medical information products and services, today announced the launch of SciVerse, an innovative platform that integrates the company's key products and encourages the scientific community to collaborate on the development of customized search and discovery applications. Elsevier has committed to releasing the APIs for all of the content on SciVerse and will offer application development support tools on the site.
Nearly five million Americans live with heart failure, with as many as 700,000 new cases diagnosed each year. In addition to lifestyle factors, scientists have shown that heart failure has a strong heritable component, but identifying the responsible genes has been a major challenge. Now, new research has identified a common genetic risk factor for heart failure in Caucasians that is also linked to kidney function.
ImmunoGen, Inc., a biotechnology company with a proprietary Targeted Antibody Payload (TAP) technology, today announced that Roche is implementing a "three-pronged approach" to developing trastuzumab emtansine (T-DM1) for early stage HER2-positive breast cancer, according to plans outlined by Roche at its 2012 ASCO analyst event.
› Verified 7 days ago
Mrs. Sarah Jane Ingle, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5311 Longwood Ave, Parma, OH 44134 Phone: 440-885-8308 | |
Vanessa Mary Spring, MED Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5311 Longwood Ave, Parma, OH 44134 Phone: 440-885-5300 | |
Mrs. Michelle Dawn Miller, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5520 Broadview Rd, Parma, OH 44134 Phone: 812-243-6611 | |
Mrs. Anne Cary, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6149 W 130th St, Parma, OH 44130 Phone: 216-344-1546 | |
Alexandra Schiefferle, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5311 Longwood Ave, Parma, OH 44134 Phone: 440-842-5300 Fax: 440-885-8304 | |
Debra Stibora, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7700 Malibu Dr, Parma, OH 44130 Phone: 440-885-8645 |